Nicole Vitullo, Director at Esperion Therapeutics, Inc. (ESPR), sold 888,779 shares at $71.79 ($2.2M) on 2018-01-25, disclosed to the SEC on 2018-01-26.
Open-market sale of $2.2M ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 850,000 | $0 | 0.0% |
| 2 | $71.82 | 117 | $8K | 0.4% |
| 3 | $71.82 | 6,814 | $489K | 22.5% |
| 4 | $71.79 | 11,674 | $838K | 38.6% |
| 5 | $71.79 | 11,674 | $838K | 38.6% |
| 6 | $0.00 | 8,500 |
| $0 |
| 0.0% |
| Total | $2.45 avg | 888,779 | $2.2M | 100% |
| Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |
| EVOK | SELL | 2016-04-27 | $415 | — | Filing → |